The #fdasm website

Digital Pharma: Counting down to the FDA’s social media hearing

November 9, 2009
Medical Communications FDA, digi, digital pharma, industry, social media

Later this week the FDA will hold its hotly anticipated hearing on pharma’s use of social media.The ‘Public Hearing

Cambrex sales rise in Q3 despite ‘challenging environment’

November 9, 2009
Manufacturing and Production, Research and Development CMO, CRO

Contract development and manufacturing services firm Cambrex saw its sales advance 2% to $58 million in the third quarter on …

Think tank ranks NHS highly

November 9, 2009
Sales and Marketing NHS

 The Department of Health has taken the opportunity to blow its own trumpet by publicising a US think tank’s report …

MBAs: broaden your horizon

November 5, 2009
Business Services MBA, careers

 Last month in Pharmafocus we looked at how the MBA has developed into an important part of the potential senior …

Novartis gets German OK for swine flu vaccine

November 5, 2009
Research and Development, Sales and Marketing Novartis, h1n1

 Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …

New Merck & Co opens for business

November 5, 2009
Sales and Marketing MA, Merck, restructure

The new corporate entity formed by the Merck & Co/Schering-Plough merger has at last opened its doors for business.The Schering-Plough …

Pfizer's Real Danger campaign

Digital Pharma: Pfizer’s multi-media dead rat

November 4, 2009
Medical Communications Pfizer, counterfeits, digi, get real

Pfizer has given a multi-media boost to its hard-hitting ‘dead rat’ campaign, which warns about the dangers of buying counterfeit …

Actelion Robin

Actelion UK appoints Robin Bhattacherjee General Manager

November 4, 2009
Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing

Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

DSM looking for new Chinese ingredient partners

November 4, 2009
Manufacturing and Production CMO, DSM

Dutch fine chemicals company DSM has said it will look for new partners in China after dissolving a joint venture …

Univar Michael

Univar Europe appoints Michael Cooke

November 3, 2009
Manufacturing and Production appointment, manufacturing and production, univar

Univar Europe has strengthened its pharma team with the appointment of Michael Cooke.Cooke, who was previously Univar’s director of safety, …

Dr John Nash, Senior Director ADME/PK, BioFocus

November 3, 2009
Research and Development appointment, biofocus, research and development

BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK.  John has …

Phase III success for GSK’s lupus drug

November 3, 2009
Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …

Whatever happened to yesterday’s ‘magic bullets’?

November 3, 2009
Research and Development Les Rose, biotech

How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …

Fast times at contract research firm PPD

November 3, 2009
Research and Development CRO

Pharmaceutical Product Development (PPD) has unveiled several new initiatives to re-inject some growth momentum into the business as its third-quarter …

UK lung cancer patients face ‘unacceptable postcode lottery’

November 3, 2009
NHS

Lung cancer patients in the UK face an "unacceptable postcode lottery", according to the first national review of lung cancer …

GSK-Genmab blood cancer drug approved in US

November 2, 2009
Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …

Lonza cuts staff, issues profits warning

November 2, 2009
Manufacturing and Production CMO

Swiss contract manufacturer and fine chemical firm Lonza has announced it will cut around 5% of its workforce and may …

Synovate Jackie

Jackie Ilacqua, head of oncology, Synovate

November 2, 2009
Sales and Marketing appointment, sales and marketing, synovate

Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.Formerly responsible for building and managing Synovate’s global …

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009
Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …

The Gateway to Local Adoption Series

Latest content